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METHODOLOGY ARTICLE

Open Access

Sequencing, identification and mapping of
primed L1 elements (SIMPLE) reveals significant
variation in full length L1 elements between
individuals
Vincent A Streva1,5, Vallmer E Jordan2, Sara Linker3, Dale J Hedges4, Mark A Batzer2 and Prescott L Deininger1*

Abstract
Background: There are over a half a million copies of L1 retroelements in the human genome which are
responsible for as much as 0.5% of new human genetic diseases. Most new L1 inserts arise from young source
elements that are polymorphic in the human genome. Highly active polymorphic “hot” L1 source elements have
been shown to be capable of extremely high levels of mobilization and result in numerous instances of disease.
Additionally, hot polymorphic L1s have been described to be highly active within numerous cancer genomes.
These hot L1s result in mutagenesis by insertion of new L1 copies elsewhere in the genome, but also have been
shown to generate additional full length L1 insertions which are also hot and able to further retrotranspose.
Through this mechanism, hot L1s may amplify within a tumor and result in a continued cycle of mutagenesis.
Results and conclusions: We have developed a method to detect full-length, polymorphic L1 elements using a
targeted next generation sequencing approach, Sequencing Identification and Mapping of Primed L1 Elements
(SIMPLE). SIMPLE has 94% sensitivity and detects nearly all full-length L1 elements in a genome. SIMPLE will allow
researchers to identify hot mutagenic full-length L1s as potential drivers of genome instability. Using SIMPLE we find
that the typical individual has approximately 100 non-reference, polymorphic L1 elements in their genome. These
elements are at relatively low population frequencies relative to previously identified polymorphic L1 elements and
demonstrate the tremendous diversity in potentially active L1 elements in the human population.
Keywords: Retrotransposon, High-throughput sequencing, LINE1, Polymorphism

Background
Mobile elements have been extremely successful at colonizing human genomes. As much as two thirds of human
genomic content is either made up of mobile elements or
mobile element relics [1,2]. The two most significant classes of human mobile elements are long interspersed elements (LINEs) and short interspersed elements (SINEs),
and together, these elements account for at least 38% of
genomic content [2,3]. In humans, the most significant
members of the LINE and SINE families are L1 and Alu,
respectively.
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L1 elements have been amplifying in mammalian genomes since before the divergence of placental and marsupial mammals 170 million years ago [4]. Since becoming
established in primate genomes (~40 million years ago),
there has been a linear evolution of L1 subfamilies, with
each newly active L1 subfamily replacing the one that came
before [5,6]. Today, the predominant active L1Hs family of
L1 retrotransposons is responsible for the majority of
known L1 retrotransposition events [4,7-10]. L1 promoters
and other functional sequences vital to L1 retrotransposition accumulate disruptive mutations as a function of time.
Hence, it is not surprising that studies have shown the elements most likely to be active are those that have most recently inserted and therefore may not have become fixed
in the population [11-13]. These polymorphic L1 elements
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are often capable of significant levels of L1 retrotransposition [11,14].
Active full length L1 is a ~6 kb long element that codes
for two open reading frames (ORFs): ORF1 which encodes
a protein with nucleic acid chaperone and RNA binding
properties, and ORF2 which encodes a protein with endonuclease (EN) and reverse transcriptase (RT) activities
[15,16]. L1 mobilizes through a process called retrotransposition [17,18]. Briefly, full length, intact L1 loci are
transcribed by RNA polymerase II, to generate a bicistronic L1 mRNA encoding two proteins, ORF1p and ORF2p
[19]. The L1 mRNA and L1 proteins form a ribonucleoprotein (L1 RNP) which enters the nucleus where the
ORF2p-encoded endonuclease (EN) and reverse transcriptase (RT) create a cDNA copy of the L1 mRNA in a
new genomic location through a process called target
primed reverse transcription (TPRT) [17,18]. Through retrotransposition, L1 has been able to amplify itself to its
current copy number of ~500,000 copies per genome.
However, the majority of these L1 elements are nonfunctional relics due to severe truncation at their 5’ ends
caused by aborted TPRT events and accumulation of deleterious mutations either over time or as a result of unfaithful RT activity [2,20-23].
An estimated 10-30% of new L1 insertions are full
length with the potential for further retrotransposition
[11]. Negative evolutionary selection leads to depletion
of the full-length elements and there are only about
5000 full-length elements in the human genome [2].
Most of these are old and mutated, and current estimates of the number of potentially active full length L1s
stand at about 80–100 per individual [11,14]. Next generation sequencing (NGS) studies have predominantly
focused on detecting L1 insertional mutagenesis through
detection of the 3’ end of L1 elements [24-27]. Through
these NGS techniques, various groups have identified
the insertional burden of L1 in germline and somatic tissues, including various cancers. Few studies, however,
focus on the specific detection of full-length L1 elements
in these genomes that could potentially be hot for retrotransposition and responsible for the accumulation of
further L1 insertion events. This is an important facet of
the retrotranspositional burden in cancers because these
full length L1 elements have been shown to be capable
of extremely high levels of continued retrotransposition
in tumors with newly inserted hot L1 copies continuing
to be actively mobile [28-30].
Studies that have looked at full-length L1 elements in
the reference build of the human genome have indicated
that the bulk of retrotransposition occurs from a handful
of hot L1 elements [11]. Additionally, full length L1 elements that are polymorphic between individuals are significantly more likely to be hot than fixed, reference full
length L1s [11,31]. Recent reports support the idea that
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different L1 elements are active in different individuals
and that single hot L1 elements can result in incredibly
high levels of insertional mutagenesis [28,29]. Additionally,
hot L1 elements in tumors have recently been shown to
mobilize to hundreds of new locations within some tumors, with some of these new insertions also further mobilizing to additional locations [30]. Despite the extensive
mutagenesis caused by hot L1s, few attempts have been
made to identify full length L1 elements in human populations that may lead to successive insertion events.
In this report, we describe a NGS-based method to
identify full length L1 elements in human genomes that
we call Sequencing Identification and Mapping of Primed
L1 Elements (SIMPLE). Using SIMPLE we have identified
228 polymorphic L1 elements in seven independent individuals. SIMPLE has 94% sensitivity and is robustly able to
identify nearly all full length L1 elements in a human genome, making it possible to identify hot L1s capable of
causing high degrees of insertional mutagenesis.

Results
Description of SIMPLE library generation

Various anchored PCR strategies have been effectively
employed to identify mobile element insertions in a
whole-genome setting. They all share the use of one primer from within the known sequence of the element, and
use different strategies to target a second primer outside
of the element. However, there are several significant
drawbacks to most of those methods. Those that ligate a
linker to a restriction site located randomly outside of the
mobile element insertion only create one amplified fragment size from each element. Thus, it is impossible to tell
whether duplicate sequences are independent ligations or
PCR duplicates. A similar argument can be made for the
use of an arbitrary primer to prime outside the mobile
element. Furthermore, restriction sites located at different
lengths away from the element will amplify with differential efficiencies, as will different arbitrary primers. Thus,
these methods require pooling of multiple experiments
using different restriction enzymes or primers to come
close to saturating the potential insertions. In addition,
even those protocols that utilize randomly sheared DNA
to apply anchors still use a major ligation step in their
preparation. These ligation steps, such as those used in
the preparation of Illumina libraries, lead to low levels of
chimeric fragment ligation between genomic fragments
that can confound data analysis [32].
Sequencing Identification and Mapping of Primed L1 Elements (SIMPLE) is a unique L1-detection method based
on the principles of random shearing combined with
t-linker ligation-mediated PCR that takes advantage of the
massive parallelization offered by high throughput NGS
technology [33]. A primer specific to the 5’ UTR of full
length L1 elements is used in a single round of primer
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extension in the 5’ direction of the L1 element, which allows for priming on all of the ~5000 full length L1 elements in the human genome and the generation of a
single adenine overhang at the end of those extended fragments (Figure 1A). The vast majority of the genome will
remain single-stranded so that little besides the extended
mobile element fragments will have the A overhang necessary for duplex linker ligation via a 3’ thymidine overhang.
Following linker ligation, PCR amplification using L1 5’
UTR and linker-specific primers allows for specific amplification of only those DNA fragments anchored by an L1
extension event (Figure 1B). Additional Illumina adapter
sequences are added in a subsequent PCR reaction and
the SIMPLE library is size fractionated on an agarose gel
before final library amplification (Figure 1C). SIMPLE libraries can be directly loaded onto the next generation sequencing platform for sequence analysis. Thus, each
sample is generated from a randomly sheared fragmentation, making it easy to differentiate PCR duplicates from
authentic detection of the same element multiple times. In
addition, we reasoned that the ligation step used in SIMPLE would be less likely to create chimeras than a
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traditional linker ligation because of the nature of the 3’
overhangs generated by primer extension and that most of
the fragments will remain single-stranded.
Validation of SIMPLE

To assess the ability of SIMPLE to detect full length L1 elements from the human genome, we sought to determine
the efficiency of SIMPLE at pulling out known, reference
full length L1 elements that are fixed in the human population. These L1 elements represent evolutionarily established L1 elements that inserted in a primate genome
before the split of Homo sapiens, and thus represent L1 elements universally present in all human genomes at a diploid level. We employed SIMPLE to determine how many
known, fixed full-length L1 elements on three randomly
selected chromosomes we could detect. We limited our
initial analysis to three chromosomes to allow a more exhaustive manual analysis of any variants. Of the 543 fixed
full-length L1 elements on three randomly selected chromosomes, SIMPLE successfully detected the vast majority
with an average read depth of ten independent (having
a different linker location) reads per element. Of these,

Figure 1 Description of SIMPLE. (A) Randomly sheared genomic DNA (black line) is subjected to a single round of primer extension using a primer
specific to the L1 5’ UTR (blue arrow). Only DNA fragments containing a full length L1 element (large red arrow) will undergo linear extension from the
L1-specific primer. DNA fragments containing no L1 sequence or truncated L1 copies (bottom left and right respectively) will not be extended. Following
primer extension, a duplex “t-linker” (orange) is ligated to L1-primer extended ends. (B) Following ligation of duplex linkers, adapter sequences needed
for Illumina sequencing (purple bars) are added by nested PCR to only those fragments anchored by an L1 extension event. (C) Following gel based size
fractionation, SIMPLE libraries are run on an agarose gel and analyzed by Agilent BioAnalyzer to confirm size and library quality.
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511/543 (94%) were detected by at least one SIMPLE read,
with 502/543 (92%) detected by more than three independent SIMPLE events (reads) (Figure 2A and B). The
32/543 (6%) full-length L1 elements not detected by SIMPLE were located in regions of repetitive DNA (nearly all
other genomic L1 elements), which confounds the bioinformatics mapping of these elements.
To determine how SIMPLE performed for nonreference full-length L1 elements (ie, those elements either
present as a single copy or not present in any given individual) we assessed the detection rate of previously
described polymorphic full-length L1 elements on the
same three chromosomes [11,25-27]. While the three
chromosomes selected were found to have 152 previously
described full-length, polymorphic elements on them, we
would only expect a small proportion of these elements to
be assayed in our individuals by SIMPLE given the polymorphic nature of these elements. In fact, SIMPLE determined that 23 of these known polymorphic full-length L1
elements were present in our tested population of seven
individuals. As with fixed L1 elements, SIMPLE performed
well for polymorphic elements, with a median of seven
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independent SIMPLE reads per polymorphic element
(Figure 2C and D). Additionally, the results of our SIMPLE analysis were compared to a lower-throughput
method which identified 68 novel full length L1 elements
in the genomes of six individuals of diverse backgrounds
[31]. Using SIMPLE, we confirmed the presence of 29/68
of these non-reference full length L1 elements in at least
one of our seven individuals, including the identification
of elements with estimated allele frequencies as low as 2%,
many of which were known to be hot for retrotransposition (Additional file 1: Table S3) [31]. These data indicate
SIMPLE is a powerful tool to detect virtually all full length
L1 elements in a given individual in a single experiment,
allowing for the detection of novel non-reference full
length L1s that may contribute to mutagenesis by
mobilization in these individuals.
Extent of full length L1 polymorphism

To determine the extent of human full length L1 polymorphism between unrelated individuals, we applied SIMPLE to seven individual genomic DNA samples from
non-related Caucasian individuals to assess the degree of

Figure 2 Validation of 5’-SIMPLE using known full length L1 elements. (A) CLC Genomics Workbench window view of a representative fixed
full length L1 element detected by SIMPLE. L1PA4 represents a known full length L1 element on chromosome 1. Small green lines at bottom are
forward SIMPLE reads, reading into the 5’ end of the L1PA4 element. (B) Frequency distribution of the number of reference full length L1 elements
detected by SIMPLE versus the number of independent SIMPLE hits detected for that element. On average, a reference full length L1 was assayed by
nine independent SIMPLE reads, with the vast majority of reference full length L1 elements assayed by at least two independent reads. (C) CLC
Genomics Workbench window view of a representative non-reference full length L1 element detected by SIMPLE. As in (A), green bars represent
forward SIMPLE reads, however in this case, there is no reference full length L1 at the expected site in the genome. (D) Frequency distribution of the
number of non-reference, known polymorphic full length L1 elements detected by SIMPLE versus the number of independent SIMPLE hits detected
for that element. On average, a non-reference full length L1 was assayed by seven independent SIMPLE reads, with the vast majority of reference full
length L1 elements assayed by at least two independent reads.
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full-length L1 polymorphism between these individuals.
For ease of analysis, SIMPLE reads mapping to known
full-length L1 elements were discarded, and only those
reads that did not represent reference elements were taken
into account for analysis.
Using SIMPLE, we detected 228 non-reference fulllength L1 elements in the genomes of seven unrelated
individuals. The range of non-reference, full-length L1
elements varied from a low of 73 per individual to a high
of 134 per individual with an average of 96 nonreference full length L1 elements per individual (Table 1).
Of the non-reference, full-length L1 elements detected
by SIMPLE, 160 were elements present in dbRIP or described by previous studies [24,26,27,31,34]. The
remaining 68 non-reference full length L1 elements detected by SIMPLE in these individuals were novel elements that had not previously been described (Table 1,
Additional file 2: Table S2).
To get a better understanding of the frequency distribution of non-reference, full-length L1 elements detected by
SIMPLE, we performed pair-wise comparisons of the
SIMPLE-detected non-reference L1 elements between
each of the 7 individuals (Figure 3). Our data reveal any
two individuals shared between 29 and 94 non-reference
full length L1 elements with the average number of nonreference L1s shared between any two individuals being
52 (Additional file 3: Figure S1A). Similar pairwise comparisons revealed any one individual has between 13 and
91 non-reference, full-length L1 elements that are not
present in another single individual with an average of 44
non-reference, full-length L1 elements not shared between
any two individuals (Figure 3A). Analysis of novel nonreference, full-length L1 elements (ie, those not previously
reported) revealed individuals contained between 9 and 26
novel non-reference full length L1 elements, with an average of 15 novel non-reference elements per individuals
(Figure 4B). Of these, most are unique to a single
Table 1 Summary of polymorphic full length L1 elements
in the seven individuals tested in this study
Individual

Total polymorphics

Total Unique (New)

1

73

7 (6)

2

75

8 (8)

3

134

28 (14)

4

120

13 (6)

5

96

6 (3)

6

91

4 (2)

7

80

3 (2)

Avg.

96

10 (6)

Column two represents the total number of polymorphic full length elements
detected in a particular individual. Column three represents the number of
non-reference full length L1 elements unique to one individual (and the number
of those that represent novel elements).

individual, but as many as 10% are shared between at least
two individuals in our sample (Figure 3B, Figure 4A,
Additional file 3: Figure S1A). Taken together, these data
indicate an individual genome may contain upwards of 90
non-reference full length L1 elements with the potential
to be active.
Validation of SIMPLE-detected polymorphisms

Non-reference, full-length L1 polymorphisms detected by
SIMPLE were subjected to PCR validation to confirm the
presence of the non-reference elements. We randomly
chose 15 non-reference, full-length L1 elements detected
by SIMPLE to perform PCR based validation using L1
junction PCR to amplify across the 5’ L1 junction. This
method allowed us to determine the 5’ junction of the
non-reference L1 element by Sanger sequencing of PCR
product. We successfully validated 15/15 (100%) SIMPLEdetected L1 polymorphisms by 5’ junction PCR and confirmed the insertions by Sanger sequencing of the 5’ junction (Figure 3C, Additional file 4: Table S4). Additionally,
a random sample of validated 5’-SIMPLE reads was also
validated for 3’ junctions. We successfully validated seven
full length SIMPLE junctions at the 3’ end, and were able
to determine polyA tail length, L1 EN cleavage site, and
target site duplication size for these polymorphic elements, which showed these elements displayed the normal
features expected of insertion by retrotransposition (short
target site duplications, polyA tails, and L1 endonuclease
consensus cleavage sites) (Additional file 5: Table S5).
Taken together, these data show SIMPLE is a robust
method for detecting non-reference full length L1
elements.
Distribution of non-reference full length L1 elements

We next analyzed the chromosomal distribution of nonreference, full-length L1 elements detected in our study.
SIMPLE successfully detected non-reference L1 elements
on all 22 autosomes and X with no significant bias for any
chromosome to harbor either a particularly high or particularly low number of non-reference, full-length L1
elements. Novel full-length L1 elements were detected
on all chromosomes except 8 and 19 (Additional file 6:
Figure S2). Analysis of the number of individuals in our cohort sharing any given non-reference full length L1 reveals
that the majority of novel full-length L1 elements detected
by SIMPLE are present in only a single individual, indicating they occur at low allele frequency. However, surprisingly, a sizeable number (38%) of novel full length L1s
were detected in at least two independent individuals. In
fact, 7/68 (10%) novel full length L1 elements detected by
SIMPLE were present in at least three independent individuals (Figure 4A). Additionally, our data show that any
individual contains on average 10 unique non-reference,
full-length L1 elements with more than half of those
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Figure 3 Significant variation in the number of non-reference full length L1 elements is observed between individuals. (A) Two-way
matrix showing the total number of polymorphic full length L1 loci present in one individual but not in another. For example, the first row represents
the number of polymorphic full length L1 elements present in individual one but not in individuals two through seven (left to right). Total numbers of
polymorphic full length L1 elements per individual are included at the end of each row and the bottom of each column for reference. Numbers vary
from a low of 13 elements in individual seven that are not found in individual six (red square) to a high of 91 elements that are found in individual
three, but are not found in individual two (blue square). (B) Similar to (A) except showing the subset of only novel (previously unreported) polymorphic
full length L1 loci present in one individual but not in another. For example, the first row represents the number of novel polymorphic full length L1
elements present in individual one but not in individuals two through seven (left to right). Total numbers of novel polymorphic full length L1 elements
per individual are included at the end of each row and the bottom of each column for reference. Numbers vary from a low of five elements in
individuals five and six that are not found in individual seven (red squares) to a high of 24 elements that are found in individual three, but are not
found in individual five (blue square). (C) Representative gels depicting 5’ flank PCR of two randomly selected non-reference full length L1 elements.
Lane labels: NTC=no template control, M=1 kb DNA ladder, Arabic numerals=individual number as per Table 1. (D) Representative gel depicting 3’ flank
PCR of non-reference full length L1 element. Lane labels are as in (C).

Figure 4 Further SIMPLE validation. (A) Frequency distribution showing the number of novel (ie, previously undescribed) non-reference
SIMPLE-detected full length L1 elements (Y-axis) versus the number of individuals in which they were detected (X-axis). A majority (42/68, 62%) of novel
non-reference full length L1 elements were detected in only one individual, however 26/68 (38%) were detected in at least two individuals and 7/68
(10%) were detected in three or more individuals. (B) Graph showing the number of novel non-reference full length L1 elements found in each
individual. Numbers ranged from three novel non-reference elements in individual seven to 28 in individual three. The average number of novel
non-reference full length L1 elements per individual was ten.
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(on average, six) having not been previously described
(Figure 4B and Table 1). However, the vast majority of the
novel full length L1s detected by our study represent relatively rare alleles that are limited to only one or two individuals in our sample. To highlight this, we compared the
allele frequencies of the 68 novel full length L1s described
by this study to the 160 previously described polymorphic
full length L1s also detected in our seven individuals. We
find that while the previously described polymorphic L1
elements range from rare to common among our seven individuals, the majority of the novel polymorphic full length
L1 elements detected by SIMPLE are unique to a single
individual (Additional file 7: Figure S3). Taken together,
these data suggest that the extent of low frequency (rare)
non-reference, full-length L1 insertion polymorphisms in
the population may be greater than expected by previous
estimates [11,12,35].
Allele frequency estimates of novel full length L1s

Because our study identified numerous novel full-length
L1s that we anticipate are present at low allele frequency
based on their frequency within our seven-individual
population (Additional file 7: Figure S3), we wanted to determine the allele frequencies of the polymorphic full
length L1 elements detected in our study in a larger population of individuals. We conducted a population study to
determine the allele frequency of 43 randomly chosen
polymorphic elements in 80 individuals from four geographically diverse backgrounds (African American, Asian,
German Caucasian, and South American). The vast majority (79%) of full-length polymorphic L1 elements tested
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existed at an allele frequency less than 50%, with most
(58%) existing at less than 25% allele frequency. Additionally, 33% of polymorphic full length L1s were rare in the
population, with allele frequencies less than 10% (Figure 5).
These frequencies remained consistent whether we looked
at the total population, or within each of the four subpopulations (Additional file 8: Figure S4). Together, these data
suggest that the polymorphic elements detected by
SIMPLE represent low frequency polymorphisms in the
population that are younger and most likely to be active.
Application of SIMPLE to L1 3’ ends

To determine if SIMPLE could be easily adapted to detect
all novel L1 insertions, we sought to modify SIMPLE to target the 3’ end of human specific L1 elements (L1Hs) because the vast majority of new L1 insertions are 5’
truncated [2,20,36,37]. We designed primers targeting only
the youngest, most active L1 subfamilies and performed
SIMPLE targeting L1Hs 3’ ends in a single individual. To
determine the sensitivity of L1 SIMPLE for L1 3’ ends, we
performed a similar analysis to that done in Figure 2B. By
mapping 3’-SIMPLE data to the human genome reference
build and assaying three random chromosomes for detection of known L1Hs 3’ ends, we determined SIMPLE performs similarly for L1 3’ ends as it does for 5’ ends,
detecting 93% of known L1Hs elements on the three chromosomes assayed (Figure 6A). Like with 5’-SIMPLE, those
elements not detected by 3’-SIMPLE are elements located
in areas rich in repetitive DNA sequences, compounding
mapping. Like 5’-SIMPLE, 3’-SIMPLE is able to detect
L1Hs 3’ ends with high confidence with an average of seven

Figure 5 Allele frequency determination of full length polymorphic L1s. The allele frequency of 40 randomly selected full length polymorphic
L1s detected by SIMPLE was determined by screening a panel of 80 unrelated individuals from four distinct populations. Most polymorphic L1s tested
were found to be low allele frequency elements, with only very few elements existing at allele frequencies above 50%.
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Figure 6 Adaptation of SIMPLE to detect L1 3’ ends. (A) CLC Genomics Workbench window view of a representative fixed human specific L1
element (L1Hs) detected by 3’-SIMPLE. L1Hs represents a known human specific L1 element on chromosome 1. Small red lines at bottom are reverse
3’-SIMPLE reads, reading into the3 end of the L1Hs element. (B) Frequency distribution of the number of reference L1Hs elements detected by
3’-SIMPLE versus the number of independent 3’-SIMPLE hits detected for that element. On average, a reference L1Hs element was assayed by seven
independent 3’-SIMPLE reads, with the vast majority of reference L1Hs elements assayed by at least two independent reads.

independent 3’-SIMPLE hits per known L1Hs (Figure 6B).
These results support the use of SIMPLE for detection of
de novo L1 insertion events, which would prove useful in
studying L1 mutagenesis in various cancer types.

Discussion
Full length polymorphic L1 elements are responsible for
virtually all of the disease-causing retroelement insertions
and the bulk of retroelement mobilization observed in tumors. We have developed a robust tool to identify fulllength polymorphic L1 elements in individual genomes,
which also has potential to be applied to the detection of
de novo somatic L1 insertion events in tumors or other
samples. Because DNA fragmentation for SIMPLE occurs
by random shearing of genomic DNA by sonication, SIMPLE is able to detect L1 elements that may be located too
distally from restriction enzyme cut sites used by other
high-throughput sequencing methods [25,26]. Additionally, SIMPLE has benefits over other fosmid-based approaches used in the past in that it is extremely high
throughput, allowing the detection of essentially all genomic L1 elements in a single SIMPLE reaction [31]. Those
rare elements missed by SIMPLE, which reside within repetitive regions of the genome (ie, other L1 elements) are
likely a function of read length. It is possible that future iterations of SIMPLE using longer reads would allow for
exact mapping of reads that lie partially within repetitive
genomic regions.
Using SIMPLE, we have determined the typical individual contains about 100 non-reference, full-length L1 elements. Based on previous estimates, we expect 63/100 of
these elements to be active, with 54/100 exhibiting particularly high levels of activity [31]. These 100 nonreference, full-length L1 elements are in addition to the
active polymorphic L1 elements present in the human

genome reference build, indicating the potential burden of
active L1s in any one individual exceeds previous estimates of 80–100 elements per individual [11]. Additionally, our results indicate that the number of non-reference,
full-length L1 elements in the population likely exceeds
previous estimates given the finding that a number of
novel elements detected by SIMPLE were present in multiple individuals. Further, the variation we see between individuals in terms of the number of non-reference, fulllength L1 elements implies there are likely individual differences in each person’s “retrotransposition potential”,
with some individuals in a population being more prone
to L1 jumping than others, which is consistent with previous hypotheses [38] as well as with recent data showing
some hot L1s are differentially active between different
cancer [28-30].
It is interesting to note that although all seven individuals
assayed in this study were Caucasian, there is still significant variation between individuals with respect to nonreference, full-length L1 elements. We anticipate, however,
that analysis of diverse populations will yield similar results
in terms of absolute numbers to those reported here. We
would expect an individual from any single population to
harbor the average 100 non-reference full length L1 elements with the only difference being in the identity of the
particular elements found in that individual. Two individuals from similar backgrounds will share a greater number
of non-reference elements than two individuals from diverse backgrounds, but both individuals will have ~100
non-reference full length L1 elements each regardless of
their background.

Conclusion
SIMPLE represents a useful tool not only for both
population and tumor-based studies of L1 insertion
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polymorphism. The vast majority of L1 retrotransposition is likely to occur due to the approximately 100 polymorphic L1 loci in each individual. Work looking at L1
mobilization in tumors has identified a number of tumor
types that appear to support L1 mobilization (colorectal,
prostate, lung, ovarian) as well as others that do not
(glioblastoma, multiple myeloma) [25-27,39,40]. While
this preference for particular tumor types can be explained by cell-specific factors affecting L1 mobilization,
there is also significant variation in the extent of L1
mobilization within cancers of the same type that could
be due to differences in polymorphic, active L1 elements
between two individuals [27,40]. Using SIMPLE, it may
be possible to determine the nature of biases in L1 retrotransposition rates between different individuals or tumors and attribute them to differences in the number or
location of active L1 elements between two individuals.
Additionally, with the application of SIMPLE to L1Hs 3’
ends, it can be used to determine the total levels of L1
retrotransposition in different individuals and tumors.

Methods
Cell lines and oligonucleotides

Fibroblast cell lines GM01631, GM01632, GM05510,
GM05568, GM16094, GM15983, and GM08207 were
obtained from the Coriell Institute (Camden, NJ). Cell
lines were maintained in EMEM supplemented with
non-essential amino acids, sodium pyruvate, and 10%
fetal bovine serum. DNA oligonucleotides and duplex
linkers were obtained from Integrated DNA Technologies (Coralville, IA). Oligonucleotide sequences used in
this study are presented in Additional file 9: Table S1.
5’ SIMPLE library generation

Genomic DNA from fibroblast cell lines was extracted
using the DNEasy Blood and Tissue Kit from Qiagen
(Germantown, MD). DNA was sheared to approximate
750-1200 bp using a Diagenode BioRuptor on High, 30s
on/30s off for 12 minutes. 50 ng of sheared gDNA was
subject to a primer extension reaction using Taq polymerase and a L1 5’ UTR specific primer (L15’UTRP1) which
sits ~100 bp from the start of the L1 element. Phosphorylated duplex T-linkers (IDT, Coralville, IA) were ligated
using T4 DNA ligase. First round PCR was performed for
20 cycles using primers L15’UTRP1 and LinkerP1. Onemillion fold dilution of PCR I was performed and 1uL of
this dilution was subjected to a nested PCR using primers
L15’UTRP2 and LinkerP1 for 25 cycles. PCR products
were run on a gel and a gel slice at ~500-700 bp was extracted using the Qiagen Gel Extraction kit. Following extraction, the final library was amplified using Phusion
polymerase (Thermo, Waltham, MA) for 12 cycles as per
the Illumina library generation protocol, and gel purified
to yield the final 500-700 bp library.
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Library quantitation and illumina sequencing

Illumina sequencing libraries were quantified by qPCR
and checked for quality by Agilent BioAnalyzer trace at
Elim Biopharmaceuticals (Hayward, CA). 100 bp paired
end Illumina sequencing was performed on an Illumina
HiSeq 2000 by Elim Biopharmaceuticals (Hayward, CA).
Reference genome masking

Reference repetitive element annotation files were downloaded from UCSC genome browser as GTF files and
used to annotate the GRCh37 (hg19) reference genome
in CLC Genomics Workbench (CLC Bio, Cambridge
MA). Two custom GFF annotation files were also generated: 1) representing known polymorphic elements and
2) representing all known full length L1 elements plus
600 bp of upstream genomic flanking sequence.
To identify and annotate 5’ L1 regions of the genome,
the first 300 base pairs of the L1.3 consensus sequence
was aligned to the human reference genome (CRCh37/
hg19) via NCBI BLAST (blastn algorithm). Initial search
parameters were relaxed to increase sensitivity for older,
more mutated elements (word size=7, gap cost=3, gap
extension cost=3, match score=2, mismatch penalty=−3,
minimum E score of 10). Blast output was generated in
tabular format. Because many of the hits obtained from
this search consisted of isolated smaller regions
(20-30 bp) that were independent of any identifiable L1
element, we further filtered for those hits where alignments were made across >=250 bp of the 300 bp query.
This greatly improved our specificity while maintaining
sensitivity to older, more mutated elements. Tabular
format blast results were converted to GFF via Perl
scripting, and an additional 600 bp of flanking sequence
was added upstream and downstream to each matching
position.
Annotation of 3’ L1 ends and flanking sequenced was
performed using a similar strategy as above, except that
initial identification of 3’ end locations was based on the
UCSC Genome Browser hg19 RepeatMasker table track,
which allowed for subfamily classification based on all
available sequence from the insertion.
5’ SIMPLE mapping strategy

FASTQ sequencing files were analyzed for quality using
FastQC. PCR duplicate reads were removed using custom in-house Perl scripting. Sequence read mappings
were performed using CLC Genomics Workbench.
Single end genomic flank reads were mapped using a
two-pronged mapping strategy. First, reads that either
mapped to within 600 bp of known, fixed full length L1
elements or those reads that did not map unambiguously were discarded, as they represented either known
elements or unmappable reads. The remaining reads
were then mapped uniquely to an annotated GRCh73/
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hg19 reference genome to identify novel polymorphic or
potentially de novo full length L1 elements.
Polymorphic full length L1 allele frequency determination
DNA samples

Confirmed novel L1 elements were genotyped to determine the allele frequency of the insert on a DNA panel
of 80 diverse individuals (20 African Americans, 20
Asians, 20 Europeans and 20 South Americans) obtained
from the Coriell Institute for Medical Research, Camden,
NJ. The efficacy of each primer pair was initially assessed
through PCR using human DNA cell line HeLa (ATCC
CCL-2) and/or chimpanzee DNA cell line Clint
(S006006), confirming the size of the predicted PCR
products.
PCR primer design

BLAT was used to locate candidate L1 sequences and
flanking DNA these sequences in the hg 19 human reference genome, and add 1,000 bp of flanking sequence
both upstream and downstream. Sequences were then
screened through RepeatMasker confirming the absence
of candidate L1 inserts from the hg 19 sequence and localizing unique genomic regions for primer design. For
the most part, prospective PCR primers flanking each
candidate L1 locus were designed using Primer3 software. Once screened through the BLAT genome
browser, primers were selected for PCR if they were predicted to amplify a single locus. In addition, a virtual
PCR was performed for each locus using the in silico
function of BLAT to compute the expected PCR product
size, annealing temperature, and further verify that only
one locus would be amplified. For candidate L1 loci directly flanked by substantial stretches (more than 1 kb) of
repetitive genomic sequence, primers were designed
manually. In such instances, flanking sequences (up to
1 kb) were screened using the BLAT genome browser and
aligned with closely reported matches (usually 4–12 loci)
in BioEdit (Ibis Biosciences). Point mutations, insertions,
and/or deletions specific to the candidate L1 loci were
manually positioned toward the 3’ end of the primers. In
addition, internal primers, purposed to anneal to the
3’ end of a full length human specific L1 element, were
available [41].
PCR analysis

PCR assays were performed in four stages. (1) An empty
site PCR analysis was initially conducted using HeLa
DNA. External primers flanking each candidate L1 locus
were used to amplify PCR products matching the predicted empty site band lengths previously generated
using BLAT’s in silico PCR feature. This assay was capable of amplifying PCR products no larger than
1,500 bp. As a result, alleles lacking the L1 insertion
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were exclusively amplified. Neither alleles possessing an
L1 insertion nor unsuitable primer pairs amplified PCR
products. Thus it was impossible to distinguish suitable
primers pairs flanking L1 inserts that were homozygous
present in HeLa DNA from an unsuccessful reaction
(failure to amplify an existing empty site). Therefore,
given the human specific nature of the predicted L1 inserts, chimpanzee DNA was used in a control PCR analysis examining each primer pair that failed to amplify
an empty site during the initial PCR. (2) An internal primer test was conducted to verify the presence of novel
L1 inserts and verify that they were full length. These
PCR analyses were performed using DNA samples from
the individual(s) in which the inserts were originally
identified, an external primer flanking the predicted 3’
end of the L1, and a 3’ internal primer [41]. (3) A long
amplification PCR was conducted to further confirm the
presence or absence of candidate L1 insertion characterized in the former stages. This assay was capable of
amplifying PCR products up to 15 kb. Thus the flanking
external primers were used to amplify the entire L1 insertion. (4) An allele frequency PCR analysis was conducted using a DNA panel of 80 individuals (20 African
Americans, 20 Asians, 20 Europeans and 20 South
Americans). This assay subjected each sample to both an
empty site assay (stage 1) and an internal primer test
(stage 2).
Stages 1, 2, and 4 were performed in 25 μL reactions
containing 25 ng of template DNA, 200 nM of each
oligonucleotide primer, 1.5 mM MgCl2, 10× PCR buffer
(50 mM KCl, 10 mM TrisHCl; pH 8.4), 0.2 mM deoxyribonucleotide triphosphates and 1 to 2 U Taq DNA polymerase. PCR reactions were performed as follows: initial
denaturation at 94°C for 60 seconds, followed by 32 cycles of denaturation at 94°C for 30 seconds, 30 seconds
at primer annealing temperature (determined previously
with HeLa DNA), and extension at 72°C for 30 seconds.
PCR reactions were terminated with a final extension at
72°C for 2 minutes. Fractionation of 20 μL of each PCR
product was performed in a horizontal gel chamber on a
2% agarose gel containing 0.2 μg/mL ethidium bromide
for 45 minutes at 200 V. UV-fluorescence was used to
visualize the amplified DNA fragments.
Stage 3 was performed using Takara LA-Taq (long
amplification) DNA polymerase (Clontech Laboratories,
Inc., Mountain View, CA). These PCR reactions were
performed in 25 μL reactions containing 25 ng of template DNA and LA-Taq PCR reagents according to the
manufacturer’s suggested protocol: initial denaturation
at 94°C for 1 minute and 20 seconds, followed by 32 cycles of denaturation at 94°C for 20 seconds, 20 seconds
at the optimized annealing temperature, and a long extension step at 68°C for eight minutes and 30 seconds.
These long-amplification reactions were terminated with
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a final extension at 68°C for 10 minutes. PCR products
were size fractionated on a 1% agarose gel for 150 minutes
to 180 minutes at 150 V. UV-fluorescence was used to
visualize the DNA fragments.

chromosome X without any apparent bias for one genomic region over
another. Novel full length L1 elements (grey) were also detected across
nearly all autosomes and chromosome X without apparent bias.
Additional file 7: Figure S3. Allele frequency of known and novel full
length L1s among the seven individuals in our population. Graph shows
the frequency (as a percentage) of known (blue bars) or novel to this
study (red bars) polymorphic full length L1 elements within our
population. Previously described polymorphic L1s show an even
distribution with some representing rare alleles (present in only one or
two individuals) and others representing common alleles (present in all
or most individuals). However, the novel polymorphic L1s show a
distribution much more skewed to rare alleles, with most novel
polymorphic L1s being unique to only a single individual.

3’-SIMPLE library generation

Library generation for 3’-SIMPLE was performed in the
same manner as 5’-SIMPLE with the following modifications. Primer extension used L1HsP1 primer. First round
PCR was 22 cycles rather than 20 and used primers
L1HsP1 and LinkerP1. Second round PCR used primers
L1HsP2 and LinkerP1. All remaining steps of 3’-SIMPLE
library generation were identical to those for 5’-SIMPLE.

Additional file 8: Figure S4. Allele frequency of 40 selected
polymorphic full length L1s from four diverse populations. Histogram
showing the allele frequencies of 40 randomly selected polymorphic full
length L1s broken down by population subtype.
20 unrelated individuals from each of four geographically distinct ethnic
groups (African American, Asian, German Caucasian, and South American)
were tested for the presence or absence of each selected polymorphic
full length L1.

3’-SIMPLE mapping strategy

Raw reads were processed for quality and duplicate removal in the same manner as for 5’-SIMPLE. A similar
two-pronged mapping strategy was used for 3’-SIMPLE
involving mapping reads to known L1Hs elements and
then taking unmapped reads and mapping unambiguously
to an annotated GRCh37/hg19 genome.

Additional files
Additional file 1: Table S3. Detection of previously reported
polymorphic full length L1s. This table shows details for 68 previously
identified polymorphic L1s [31], some of which were also detected by
this study.
Additional file 2: Table S2. Polymorphic full length L1 elements
identified in this study. This table shows details for all 228 polymorphic
full length L1s identified by this study.
Additional file 3: Figure S1. Pairwise comparison of polymorphic L1
elements shared between any two individuals. (A) Two-way matrix
showing the total number of polymorphic full length L1 loci shared
between any two individuals. For example, the first row represents the
number of polymorphic full length L1 elements shared between individual
one and each of individuals two through seven (left to right). Total numbers
of polymorphic full length L1 elements per individual are included at the
end of each row and the bottom of each column for reference. Numbers
vary from a low of 29 elements shared between individuals two and seven
(red square) to a high of 94 elements shared between individuals three and
four (blue square). (B) Similar to (A) except showing the subset of only novel
(previously unreported) polymorphic full length L1 loci shared between any
two individuals. For example, the first row represents the number of novel
polymorphic full length L1 elements shared between individual one and
each of individuals two through seven (left to right). Total numbers of novel
polymorphic full length L1 elements per individual are included at the end
of each row and the bottom of each column for reference. Numbers vary
from a low of zero elements shared between individuals one and five and
individuals two and five (red squares) to a high of eight elements that are
shared between individuals one and two and individuals three and four
(blue squares).
Additional file 4: Table S4. Validation of SIMPLE-detected full length
L1s by 5’ flank PCR. This table shows details of the validation of
SIMPLE-detected polymorphic L1s using 5’ junction PCR.
Additional file 5: Table S5. Validation of SIMPLE-detected full length
L1s by 3’ flank PCR. This table shows details of the validation of
SIMPLE-detected polymorphic L1s using 3’ junction PCR.
Additional file 6: Figure S2. Chromosomal distribution of polymorphic
full length L1 elements across seven individuals. Polymorphic full length
L1 elements were detected by SIMPLE on all autosomes and

Additional file 9: Table S1. List of oligonucleotides used in this study.
NNNNN represent random barcodes used for multiplexing.
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